9/3/2010 StockRing Buy-Sell-Hold Ratings for NASDAQ Biotechnology stocks

Receive FRESH Daily Updates for 16 StockRing Reports for $30/month !!!

1. Dow Jones Index - 30 Stocks on 9/2/2010:  Buy   17% or 5 Hold   53% or 16 Sell   30% or 9 stocks
2. Canada Toronto - 203 Stocks on 8/28/2010:  Buy   43% or 90 Hold   32% or 67 Sell   25% or 52 stocks
3. Best Brands - 200 stocks on 8/28/2010:  Buy   9% or 17 Hold   22% or 45 Sell   69% or 137 stocks
   4. World Markets - 72 Indexes on 8/28/2010:  Buy   16% or 11 Hold   21% or 15 Sell   63% or 44 indexes
5. S&P 500 Index - 500 Stocks on 7/21/2009:   Buy   68% or 341 Hold   21% or 106 Sell   11% or 53 stocks
6. S&P 400 Mid Cap - 400 Stocks on 7/21/2009:  Buy   73% or 292 Hold   15% or 61 Sell   12% or 47 stocks
7. S&P 600 Small Cap - 600 Stocks on 4/18/2009:  Buy   27% or 163 Hold   72% or 431 Sell   1% or 6 stocks
8. Nasdaq 100 Index - 100 Stocks on 6/23/2010:  Buy   38% or 38 Hold   48% or 48 Sell   14% or 14 stocks
9. Nasdaq Telecom - 164 Stocks on 7/24/2009:  Buy   49% or 81 Hold   35% or 56 Sell   16% or 27 stocks
10. Nasdaq Biotech - 136 Stocks on 7/24/2009:  Buy   57% or 78 Hold   33% or 45 Sell   10% or 13 stocks
11. Nasdaq Computer - 440 Stocks on 7/22/2009:  Buy   60% or 263 Hold   26% or 115 Sell   14% or 62 stocks
12. Nasdaq Finance - 180 Stocks on 7/24/2009:  Buy   61% or 109 Hold   6% or 12 Sell   33% or 59 stocks
13. NYSE International - 100 Stocks on 7/21/2009:  Buy   58% or 58 Hold   34% or 34 Sell   8% or 8 stocks
14. Legg Mason Mutual - 346 Funds on 10/6/2009:  Buy   38% or 133 Hold   51% or 176 Sell   11% or 37 funds
15. T. Row Price Mutual - 161 Funds on 10/6/2009:  Buy   52% or 84 Hold   46% or 73 Sell   2% or 4 funds
16. London FTSE 100 - 94 Stocks on 4/1/2009:  Buy   20% or 19 Hold   50% or 47 Sell   30% or 28 stocks

                                             TOTAL RATINGS:   Buy   58% or 1921 Hold   12% or 1331 Sell   30% or 676 stocks

9/3/2010 StockRing Buy-Sell-Hold ratings for NASDAQ Biotechnology Index stocks
Our advise: SELL 10% or 13, HOLD 33% or 45, BUY 57% or 78 of NASDAQ Index stocks
All Sell & Super Sell Sell Super Sell Hold Buy & Super Buy Buy Super Buy
NASDAQ Biotechnology Index Chart for 1 year 9/3/2010 (Irvine, California) Today StockRing.com analyzed 136 stocks from NASDAQ Biotechnology Index and found that 10% or 13 got a SELL rating. Only 57% or 78 stocks got a BUY rating, while another 33% or 45 stocks got a HOLD rating out of all stocks from NASDAQ Biotechnology Index. Current Market outlook is extremely negative and we anticipate further market declines across all US and most World stocks market indexes. According to our model the government would not be able to compensate the market with enough liquidity to achieve normal operations. This would lead to even more declines in all major stock market sectors. By the way, StockRing found 2 stocks with SUPER SELL rating and 24 stocks with SUPER BUY rating. People who will suffer the most will be the owners of mutual fund shares. According to our scenario mutual funds will not be able quickly exit from their rapidly declining positions and would have to bear the most losses from more active players on the market. Also, a few very well organized stock market players are trading a lot in stock options and are securing currently very high prices for a lot of stocks while anticipating a major decline in their share prices. In the recent year the most profitable strategy was buying put options on all major stocks that consistently declined all year long from S&P 500 index in 2008. At this time StockRing recommends to buy SHORT positions on many stocks from S&P 500 Index stocks that currently have a SELL or SUPER SELL rating. If you decide to take a LONG position and actually buy some stocks right now - please check the section of S&P 500 index stocks that have a BUY or SUPER BUY rating. If you would like to receive Buy-Sell-Hold ratings specifically for your stocks and not just for stocks from S&P 500 Index, then please register for a Free 2 week trial with StockRing.com and begin receiving your weekly reports with Buy-Sell-Hold ratings for all your stocks! StockRing will completely automate your investment steps and quickly calculate which stocks you should SELL right now and which ones to BUY. All you have to do is sit and watch how StockRing software will manage and grow your invested wealth. Receive FRESH Daily Updates for 16 StockRing Reports for $30/month !!!
9/3/2010 StockRing Buy-Sell-Hold ratings for NASDAQ Biotechnology Index stocks
StockRing advise: SELL 10% or 13, HOLD 33% or 45, BUY 57% or 78 of NASDAQ Index stocks
All Sell & Super Sell Sell Super Sell Hold Buy & Super Buy Buy Super Buy
Symbol	Buy	Hold	Sell	Name	Last Trade		Change		Volume
1. ACAD				BUY - ACADIA Pharmaceuticals Inc. (NGM : ACAD)	4:00pm	1.03	-0.01	-0.96%	93,157
2. ACOR				HOLD - Acorda Therapeutics, Inc. (NGM : ACOR)	3:59pm	32.65	+0.74	+2.32%	412,663
3. ADLR				SELL - Adolor Corporation (NGM : ADLR)	3:59pm	1.11	0.00	0.00%	94,159
4. AFFX				HOLD - Affymetrix, Inc. (NasdaqNM : AFFX)	4:00pm	4.47	+0.08	+1.82%	776,409
5. AGEN				HOLD - Antigenics Inc. (NCM : AGEN)	3:59pm	0.785	+0.0243	+3.19%	272,088
6. AKRX				BUY - Akorn, Inc. (NGM : AKRX)	4:00pm	3.74	+0.06	+1.63%	625,040
7. ALKS				BUY - Alkermes, Inc. (NasdaqNM : ALKS)	4:00pm	14.24	+0.31	+2.23%	649,391
8. ALNY				HOLD - Alnylam Pharmaceuticals, Inc. (NasdaqNM : ALNY)	4:00pm	14.81	0.00	0.00%	110,418
9. ALTH				HOLD - Allos Therapeutics, Inc. (NGM : ALTH)	4:00pm	4.08	+0.09	+2.26%	610,008
10. ALTU				HOLD - Altus Pharmaceuticals Inc. (N/A : ALTU)	N/A	0.00	N/A	N/A	N/A
11. ALXA				BUY - Alexza Pharmaceuticals, Inc. (NGM : ALXA)	4:00pm	3.02	-0.06	-1.95%	873,141
12. ALXN				BUY - Alexion Pharmaceuticals, Inc. (NasdaqNM : ALXN)	4:00pm	58.18	+0.06	+0.10%	359,759
13. AMAG				HOLD - AMAG Pharmaceuticals, Inc. (NGM : AMAG)	3:59pm	25.42	+0.18	+0.71%	283,496
14. AMGN				SUPER BUY - Amgen Inc. (NasdaqNM : AMGN)	4:00pm	52.91	+0.40	+0.76%	5,360,930
15. AMLN				SUPER BUY - Amylin Pharmaceuticals, Inc. (NasdaqNM : AMLN)	3:59pm	21.56	+0.12	+0.56%	1,159,559
16. AMRI				BUY - Albany Molecular Research, Inc. (NasdaqNM : AMRI)	3:59pm	6.43	-0.06	-0.92%	58,102
17. ANPI				HOLD - Angiotech Pharmaceuticals, Inc. (NasdaqNM : ANPI)	4:00pm	0.44	+0.0018	+0.41%	66,585
18. ARIA				HOLD - ARIAD Pharmaceuticals, Inc. (NGM : ARIA)	4:00pm	3.57	+0.02	+0.56%	824,534
19. ARNA				BUY - Arena Pharmaceuticals, Inc. (NGM : ARNA)	4:00pm	6.86	+0.12	+1.78%	5,778,803
20. ARQL				BUY - ArQule, Inc. (NGM : ARQL)	4:00pm	5.40	-0.02	-0.37%	558,993
21. ARRY				BUY - Array BioPharma Inc. (NGM : ARRY)	4:00pm	2.81	-0.04	-1.40%	165,315
22. AUXL				BUY - Auxilium Pharmaceuticals, Inc. (NasdaqNM : AUXL)	4:00pm	27.48	-0.14	-0.51%	639,308
23. AVII				BUY - AVI BioPharma, Inc. (NGM : AVII)	3:59pm	2.18	+0.04	+1.87%	1,290,079
24. BCRX				HOLD - BioCryst Pharmaceuticals, Inc. (NGM : BCRX)	4:00pm	5.36	+0.04	+0.75%	475,489
25. BIIB				HOLD - Biogen Idec Inc (NasdaqNM : BIIB)	4:00pm	56.24	+0.99	+1.79%	1,490,935
26. BIOD				BUY - Biodel Inc. (NGM : BIOD)	4:00pm	4.01	+0.13	+3.35%	333,880
27. BJGP				BUY - BMP Sunstone Corporation (NGM : BJGP)	4:00pm	7.37	+0.22	+3.08%	207,659
28. BMRN				SELL - BioMarin Pharmaceutical Inc. (NasdaqNM : BMRN)	4:00pm	21.50	+0.21	+0.99%	411,754
29. BMTI				HOLD - BioMimetic Therapeutics, Inc. (NGM : BMTI)	3:59pm	9.63	-0.07	-0.72%	102,363
30. CADX				BUY - Cadence Pharmaceuticals, Inc. (NGM : CADX)	4:00pm	8.11	+0.09	+1.12%	94,172
31. CALP				HOLD - Caliper Life Sciences Inc (NGM : CALP)	4:00pm	3.62	+0.06	+1.69%	88,903
32. CBRX				SELL - Columbia Laboratories, Inc. (NGM : CBRX)	3:59pm	1.06	-0.01	-0.93%	66,545
33. CBST				BUY - Cubist Pharmaceuticals, Inc. (NasdaqNM : CBST)	4:00pm	22.41	-0.04	-0.18%	752,167
34. CEGE				HOLD - Cell Genesys, Inc. (NGM : CEGE)	N/A	0.36	0.00	0.00%
35. CELG				BUY - Celgene Corporation (NasdaqNM : CELG)	4:00pm	53.28	+0.25	+0.47%	2,162,532
36. CEPH				BUY - Cephalon, Inc. (NasdaqNM : CEPH)	4:00pm	60.77	+0.81	+1.35%	815,404
37. CERS				HOLD - Cerus Corporation (NGM : CERS)	3:59pm	3.13	0.00	0.00%	156,984
38. CRA				SELL - Celera Corporation (NasdaqNM : CRA)	3:59pm	7.01	+0.08	+1.15%	252,533
39. CRME				HOLD - Cardiome Pharma Corporation (NGM : CRME)	3:59pm	6.37	-0.19	-2.90%	295,081
40. CRXL				SUPER BUY - Crucell NV (NasdaqNM : CRXL)	3:59pm	19.595	+0.025	+0.13%	56,330
41. CRXX				HOLD - CombinatoRx, Incorporated (NGM : CRXX)	4:00pm	1.38	+0.07	+5.34%	1,183,697
42. CVTX				HOLD - CV Therapeutics, Inc. (N/A : CVTX)	N/A	0.00	N/A	N/A	N/A
43. CYPB				BUY - Cypress Bioscience, Inc. (NGM : CYPB)	4:00pm	3.37	-0.02	-0.59%	360,705
44. CYTK				BUY - Cytokinetics, Incorporated (NGM : CYTK)	4:00pm	2.30	+0.03	+1.32%	99,049
45. DEPO				SUPER BUY - Depomed, Inc. (NGM : DEPO)	3:59pm	3.86	-0.06	-1.53%	248,307
46. DNDN				HOLD - Dendreon Corporation (NGM : DNDN)	4:00pm	40.87	+0.29	+0.71%	2,890,131
47. DRRX				HOLD - Durect Corporation (NGM : DRRX)	4:00pm	2.20	-0.06	-2.65%	142,551
48. DSCO				HOLD - Discovery Laboratories, Inc. (NCM : DSCO)	3:59pm	0.239	+0.017	+7.66%	1,670,526
49. DYAX				SUPER BUY - Dyax Corp. (NGM : DYAX)	4:00pm	2.35	+0.04	+1.73%	230,225
50. ENDP				BUY - Endo Pharmaceuticals Holdings I (NasdaqNM : ENDP)	4:00pm	28.69	+0.54	+1.92%	1,621,190
51. ENZN				BUY - Enzon Pharmaceuticals, Inc. (NGM : ENZN)	4:00pm	10.79	+0.21	+1.98%	377,560
52. EURX				BUY - Eurand N.V. (NGM : EURX)	4:00pm	9.33	+0.20	+2.19%	52,104
53. EXEL				BUY - Exelixis, Inc. (NasdaqNM : EXEL)	4:00pm	3.80	+0.30	+8.57%	2,188,485
54. FLML				BUY - Flamel Technologies S.A. (NGM : FLML)	3:58pm	7.04	+0.21	+3.07%	21,049
55. GENZ				SUPER SELL - Genzyme Corporation (NasdaqNM : GENZ)	4:00pm	70.49	-0.31	-0.44%	2,609,435
56. GERN				SUPER BUY - Geron Corporation (NGM : GERN)	4:00pm	4.94	+0.05	+1.02%	902,760
57. GHDX				SELL - Genomic Health, Inc. (NGM : GHDX)	3:59pm	14.98	+0.08	+0.54%	53,353
58. GILD				BUY - Gilead Sciences, Inc. (NasdaqNM : GILD)	4:00pm	34.02	+0.87	+2.62%	11,181,965
59. GNVC				BUY - GenVec, Inc. (NGM : GNVC)	3:59pm	0.475	+0.0107	+2.30%	314,282
60. GPRO				HOLD - Gen-Probe Incorporated (NasdaqNM : GPRO)	4:00pm	46.66	+0.81	+1.77%	236,322
61. GTXI				HOLD - GTx, Inc. (NGM : GTXI)	3:58pm	3.15	+0.11	+3.62%	66,401
62. HALO				HOLD - Halozyme Therapeutics, Inc. (NGM : HALO)	3:59pm	7.99	+0.08	+1.01%	421,886
63. HBIO				BUY - Harvard Bioscience, Inc. (NGM : HBIO)	3:44pm	3.44	+0.06	+1.78%	9,900
64. HGSI				HOLD - Human Genome Sciences, Inc. (NGM : HGSI)	4:00pm	30.13	+0.26	+0.87%	1,598,393
65. HITK				SUPER BUY - Hi-Tech Pharmacal Co., Inc. (NasdaqNM : HITK)	4:00pm	18.87	+0.30	+1.62%	118,674
66. IDEV				HOLD - Indevus Pharmaceuticals Inc. (N/A : IDEV)	N/A	0.00	N/A	N/A	N/A
67. IDIX				HOLD - Idenix Pharmaceuticals, Inc. (NGM : IDIX)	4:00pm	5.99	+0.06	+1.01%	147,692
68. ILMN				BUY - Illumina, Inc. (NasdaqNM : ILMN)	4:00pm	44.61	-0.15	-0.34%	463,547
69. IMGN				BUY - ImmunoGen, Inc. (NGM : IMGN)	4:00pm	5.62	0.00	0.00%	843,132
70. IMMU				HOLD - Immunomedics, Inc. (NGM : IMMU)	4:00pm	2.95	-0.05	-1.67%	419,761
71. INCY				SUPER BUY - Incyte Corporation (NGM : INCY)	4:00pm	13.55	+0.30	+2.26%	2,006,982
72. ISIS				BUY - Isis Pharmaceuticals, Inc. (NasdaqNM : ISIS)	3:59pm	8.20	+0.08	+0.99%	598,430
73. ISPH				BUY - Inspire Pharmaceuticals, Inc. (NGM : ISPH)	4:00pm	4.96	-0.06	-1.20%	299,314
74. ITMN				HOLD - InterMune, Inc. (NasdaqNM : ITMN)	4:00pm	11.65	+0.34	+3.01%	1,586,748
75. LGND				HOLD - Ligand Pharmaceuticals Incorpor (NGM : LGND)	4:00pm	1.53	0.00	0.00%	173,893
76. LIFE				SUPER BUY - Life Technologies Corporation (NasdaqNM : LIFE)	4:00pm	46.01	+1.02	+2.27%	1,255,389
77. LMNX				HOLD - Luminex Corporation (NGM : LMNX)	4:00pm	15.17	+0.27	+1.81%	65,936
78. LXRX				BUY - Lexicon Pharmaceuticals, Inc. (NGM : LXRX)	4:00pm	1.45	-0.02	-1.36%	514,093
79. MAXY				BUY - Maxygen, Inc. (NGM : MAXY)	4:00pm	5.72	0.00	0.00%	80,564
80. MBRK				BUY - MiddleBrook Pharmaceuticals, In (N/A : MBRK)	N/A	0.00	N/A	N/A	N/A
81. MDCO				HOLD - Medicines Company (The) (NasdaqNM : MDCO)	4:00pm	11.89	+0.15	+1.28%	398,888
82. MDVN				BUY - Medivation, Inc. (NGM : MDVN)	4:00pm	10.30	+0.07	+0.68%	145,031
83. MEDX				HOLD - Medarex, Inc. (N/A : MEDX)	N/A	0.00	N/A	N/A	N/A
84. MGRM				HOLD - Monogram Biosciences, Inc. (N/A : MGRM)	N/A	0.00	N/A	N/A	N/A
85. MITI				SUPER BUY - Micromet, Inc. (NGM : MITI)	4:00pm	6.61	+0.06	+0.92%	211,411
86. MNKD				BUY - MannKind Corporation (NGM : MNKD)	4:00pm	5.81	+0.06	+1.04%	963,283
87. MNTA				SELL - Momenta Pharmaceuticals, Inc. (NGM : MNTA)	4:00pm	14.69	+0.25	+1.73%	730,918
88. MTXX				HOLD - Matrixx Initiatives Inc. (NasdaqNM : MTXX)	3:59pm	5.07	-0.19	-3.61%	41,185
89. MYGN				HOLD - Myriad Genetics, Inc. (NasdaqNM : MYGN)	3:59pm	16.11	+0.01	+0.06%	854,315
90. NABI				SUPER SELL - Nabi Biopharmaceuticals (NGM : NABI)	4:00pm	5.06	-0.06	-1.17%	153,954
91. NBIX				HOLD - Neurocrine Biosciences, Inc. (NasdaqNM : NBIX)	4:00pm	5.73	+0.08	+1.42%	266,613
92. NKTR				SUPER BUY - Nektar Therapeutics (NasdaqNM : NKTR)	4:00pm	14.17	-0.03	-0.21%	496,671
93. NOVN				HOLD - Noven Pharmaceuticals, Inc. (N/A : NOVN)	N/A	0.00	N/A	N/A	N/A
94. NPSP				HOLD - NPS Pharmaceuticals, Inc. (NGM : NPSP)	4:00pm	6.58	-0.11	-1.64%	238,243
95. NVAX				BUY - Novavax, Inc. (NGM : NVAX)	4:00pm	2.31	-0.01	-0.43%	389,871
96. OMPI				SUPER BUY - Obagi Medical Products, Inc. (NasdaqNM : OMPI)	4:00pm	10.80	+0.19	+1.79%	56,120
97. ONXX				SUPER BUY - ONYX Pharmaceuticals, Inc. (NasdaqNM : ONXX)	4:00pm	25.84	+0.38	+1.49%	669,054
98. OPTR				SUPER BUY - Optimer Pharmaceuticals, Inc. (NGM : OPTR)	4:00pm	8.20	-0.03	-0.36%	233,420
99. OREX				SUPER BUY - Orexigen Therapeutics, Inc. (NGM : OREX)	4:00pm	5.42	-0.01	-0.18%	2,110,842
100. OSIP				BUY - OSI Pharmaceuticals Inc. (N/A : OSIP)	N/A	0.00	N/A	N/A	N/A
101. OSIR				HOLD - Osiris Therapeutics, Inc. (NGM : OSIR)	4:00pm	6.94	+0.31	+4.68%	38,908
102. PDLI				SUPER BUY - PDL BioPharma, Inc. (NasdaqNM : PDLI)	4:00pm	5.78	0.00	0.00%	2,854,312
103. PGNX				SELL - Progenics Pharmaceuticals Inc. (NGM : PGNX)	4:00pm	4.39	+0.04	+0.92%	100,162
104. POZN				BUY - Pozen, Inc. (NGM : POZN)	4:00pm	6.56	-0.23	-3.39%	578,474
105. PRGO				SUPER BUY - Perrigo Company (NasdaqNM : PRGO)	3:59pm	58.26	+0.36	+0.62%	892,354
106. PTIE				SELL - Pain Therapeutics (NasdaqNM : PTIE)	4:00pm	5.78	-0.13	-2.20%	88,632
107. QGEN				SUPER BUY - Qiagen N.V. (NasdaqNM : QGEN)	4:00pm	18.81	+0.37	+2.01%	1,238,236
108. QLTI				BUY - QLT Inc. (NasdaqNM : QLTI)	4:00pm	5.96	+0.12	+2.05%	86,595
109. REGN				BUY - Regeneron Pharmaceuticals, Inc. (NasdaqNM : REGN)	4:00pm	24.58	+0.46	+1.91%	314,136
110. RIGL				BUY - Rigel Pharmaceuticals, Inc. (NGM : RIGL)	4:00pm	8.45	-0.03	-0.35%	168,226
111. SEPR				HOLD - Sepracor Inc. (NasdaqNM : SEPR)	N/A	22.85	0.00	0.00%
112. SGEN				BUY - Seattle Genetics, Inc. (NGM : SGEN)	4:00pm	12.41	+0.30	+2.48%	569,340
113. SGMO				SUPER BUY - Sangamo BioSciences, Inc. (NGM : SGMO)	4:00pm	3.19	+0.09	+2.90%	268,119
114. SHPGY				HOLD - Shire plc (NasdaqNM : SHPGY)	3:59pm	67.44	+0.33	+0.49%	238,525
115. SLXP				BUY - Salix Pharmaceuticals, Ltd. (NasdaqNM : SLXP)	4:00pm	40.17	+0.54	+1.36%	450,858
116. SNTA				HOLD - Synta Pharmaceuticals Corp. (NGM : SNTA)	3:59pm	2.93	+0.04	+1.38%	88,092
117. SNTS				BUY - Santarus, Inc. (NGM : SNTS)	4:00pm	2.25	0.00	0.00%	186,118
118. SQNM				BUY - Sequenom, Inc. (NGM : SQNM)	4:00pm	6.20	+0.01	+0.16%	1,184,543
119. STEM				HOLD - StemCells, Inc. (NGM : STEM)	4:00pm	0.782	+0.002	+0.26%	800,250
120. SUPG				HOLD - SuperGen, Inc. (NGM : SUPG)	4:00pm	2.06	+0.03	+1.48%	142,807
121. SVNT				SUPER BUY - Savient Pharmaceuticals Inc (NGM : SVNT)	4:00pm	14.92	-0.08	-0.53%	1,205,505
122. TECH				BUY - Techne Corporation (NasdaqNM : TECH)	3:59pm	60.00	+0.75	+1.27%	120,852
123. TELK				BUY - Telik, Inc. (NCM : TELK)	3:59pm	0.70	-0.0076	-1.07%	5,950
124. TEVA				SUPER BUY - Teva Pharmaceutical Industries (NasdaqNM : TEVA)	3:59pm	51.78	+0.27	+0.52%	3,061,095
125. THRX				HOLD - Theravance, Inc. (NGM : THRX)	4:00pm	13.66	+0.57	+4.35%	457,751
126. TRMS				HOLD - Trimeris, Inc. (NGM : TRMS)	3:58pm	2.247	-0.043	-1.88%	13,796
127. UTHR				BUY - United Therapeutics Corporation (NasdaqNM : UTHR)	4:00pm	49.90	+1.35	+2.78%	823,707
128. VNDA				HOLD - Vanda Pharmaceuticals Inc. (NGM : VNDA)	4:00pm	6.83	+0.25	+3.80%	137,195
129. VPHM				BUY - ViroPharma Incorporated (NasdaqNM : VPHM)	4:00pm	13.55	+0.46	+3.51%	950,399
130. VRTX				BUY - Vertex Pharmaceuticals Incorpor (NasdaqNM : VRTX)	4:00pm	36.06	+0.61	+1.72%	808,208
131. VRUS				SUPER BUY - Pharmasset, Inc. (NGM : VRUS)	4:00pm	26.14	+1.18	+4.73%	75,180
132. VVUS				SUPER BUY - VIVUS, Inc. (NGM : VVUS)	4:00pm	6.26	-0.08	-1.26%	3,698,494
133. WCRX				SUPER BUY - Warner Chilcott Limited (NasdaqNM : WCRX)	4:00pm	29.28	-0.09	-0.31%	1,039,326
134. XNPT				HOLD - XenoPort, Inc. (NasdaqNM : XNPT)	3:59pm	6.02	+0.15	+2.56%	269,022
135. XOMA				SELL - XOMA Ltd. (N/A : XOMA)	N/A	0.00	N/A	N/A	N/A
136. ZGEN				BUY - ZymoGenetics, Inc. (NGM : ZGEN)	3:59pm	5.51	+0.13	+2.42%	360,996
9/3/2010 StockRing Buy-Sell-Hold ratings for NASDAQ Biotechnology Index stocks
StockRing advise: SELL 10% or 13, HOLD 33% or 45, BUY 57% or 78 of NASDAQ Index stocks
All Sell & Super Sell Sell Super Sell Hold Buy & Super Buy Buy Super Buy
Last Changes: Fri, Sep 3, 2010

Receive FRESH Daily Updates for 16 StockRing Reports for $30/month !!!

9/3/2010 StockRing Business News about NASDAQ-BIO Stock Market Index

Genzyme's Termeer, Biotechnology Pioneer, May Sell
Bloomberg
Termeer also discusses the prospects for Genzyme and the biotechnology industry. (Source: Bloomberg) Henri Termeer, a biotech industry pioneer and chief ...

and more »

Celldex plunges; drug stock indexes climb
MarketWatch
BOSTON (MarketWatch) -- Celldex Therapeutics shares plunged in early trading Friday after the biotech group announced ...

and more »

PROT, CAH, ENOC Stock Report From BestOtc.com
Penny Stock Live (blog)
PROT, a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, announced recently that Mr. ...

and more »

August's Biggest Biotech Winners
Forbes (blog)
This list is based on stock data from FactSet, and includes companies must be publicly traded on the Nasdaq or the New York Stock Exchange and have had a ...

and more »

Gleacher & Company Welcomes Another Addition to Equity Healthcare Team
MarketWatch (press release)
Mr. Huang joins Gleacher & Company from Credit Suisse where he covered Biotechnology companies across all market capitalizations. ...

and more »

RTT News

Orexigen surges on Takeda licensing deal; Vivus gains
MarketWatch
The NYSE Arca Pharmaceutical Index (NYSE:DRG) was up nominally to 291.61, and the NYSE Arca Biotechnology Index (NYSE:BTK) rose 0.8% to 1101.81.
Orexigen soars on license deal. Rexahn up on research article. BioDelivery ...BioMedReports (subscription)
Orexigen Finds A Cautious PartnerInvestopedia

all 184 news articles »

Exelixis Officers Accumulate Stock
Wall Street Journal
The insider purchases are the first at the California development-stage biotechnology company in almost two years, according to data from ...

and more »

Reuters

Genzyme rejects Sanofi bid
CBC.ca
US biotechnology company Genzyme Corp. Monday rejected an $18.5-billion US takeover bid from Paris-based rival Sanofi-Aventis SA, saying it's not enough. ...
Genzyme leads drug stocks higherMarketWatch
Sanofi-Aventis breaks silence on Genzyme acquisition, offering $18.5 billion ...The Pharma Letter
Sanofi Offers $18.5 Billion in Cash for GenzymeSan Francisco Chronicle
Local Tech Wire (blog) -International Business Times
all 1,238 news articles »

Opinions on Gilead Sciences and Incyte - Biotech Plays Losing a Little of ...
MarketWatch (press release)
The uncertainty surrounding heath care reform in the US has kept many investors away from the biotechnology industry. That coupled with the rise of generic ...

and more »

Alimera, pSivida, Bayer lead drug-stock advance
MarketWatch
BOSTON (MarketWatch) -- Alimera Sciences Inc. led drug stocks higher Tuesday afternoon as shares of the biotech group ...

and more »

Volume Hunter: Diet Stocks Lift Biotech The biotech sector was mixed on Thursday, but isolated stories sent select players soaring on notable volume spikes.

Celsion Receives SBIR Grant To Expand Its Technology Platform Celsion Corporation (Nasdaq: CLSN), a biotechnology drug development company, announced that it has been awarded a competitive Phase I Small Business Innovation and Research (SBIR) grant from the National Institutes of Health (NIH), to support the proposal, "New Thermal Sensitive Carboplatin Liposomes for Cancer". This funding will support the Company's efforts to develop its proprietary heat ...

Oncolytics Biotech(R) Inc. Announces Randomized Phase II Ovarian Cancer Study to be Conducted by the Gynecologic ... Oncolytics Biotech Inc. announced today that the Gynecologic Oncology Group intends to conduct a randomized Phase II trial of weekly paclitaxel versus weekly paclitaxel with REOLYSIN in patients with persistent or recurrent, ovarian, fallopian tube or primary peritoneal cancer .

August's Biggest Biotech Winners The five best-performing biotechnology stocks in August.

Biotech Pioneer Who Priced World's Most Expensive Drugs Loses Genzyme Grip Henri Termeer , a biotech industry pioneer and chief executive officer at Genzyme Corp ., is on the verge of losing control of a company he transformed from a start-up in 1983 into a cutting-edge drugmaker with $4.5 billion in annual sales.

Gleacher & Company Welcomes Another Addition to Equity Healthcare Team NEW YORK--(BUSINESS WIRE)--Gleacher & Company Securities, Inc., a broker-dealer subsidiary of Gleacher & Company, Inc. (Nasdaq: GLCH), today announced another addition to its Healthcare Research team with the hiring of Ying Huang. Mr. Huang joins Gleacher & Company from Credit Suisse where he covered Biotechnology companies across all market capitalizations. Prior to working on Wall Street, Mr ...

August's Biggest Biotech Losers The worst performing medical stocks of the month.

BRINAVESS™ (vernakalant) For Infusion Approved In The European Union For Rapid Conversion Of Recent Onset Atrial ... Merck (known as MSD outside the United States and Canada) (NYSE:MRK) and Cardiome Pharma Corp. (NASDAQ: CRME/ TSX: COM) announced that the intravenous (IV) formulation of BRINAVESS™ (vernakalant) has been granted marketing approval in the European Union (EU), Iceland and Norway for the rapid conversion of recent onset atrial fibrillation (AF) to sinus rhythm in adults: for non-surgery patients ...

CaPre drug candidate shows promising result on CRP level reduction Acasti Pharma Inc., a subsidiary of Neptune Technologies & Bioressources Inc. reports significant results on the effects of its anti-dyslipidemic investigational drug candidate CaPre on C-reactive protein (CRP) levels, a biomarker of CardioVascular Disease risk (CVD) and associated with diabetes and obesity.

Marina Biotech Announces Allowance of Fundamental RNAi Delivery Patent From U.S. Patent Office BOTHELL, WA--(Marketwire - 08/30/10) - Marina Biotech, Inc. (NASDAQ: MRNA - News ), a leading RNAi-based drug discovery and development company, today announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for patent application U.S. 11/745,003 broadly covering amphoteric liposomal formulations, including the Company's proprietary SMARTICLES technology, for delivery ...

Receive FRESH Daily Updates for 16 StockRing Reports for $30/month !!!